rs45622132

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_000744.7(CHRNA4):​c.1550C>T​(p.Ser517Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000268 in 1,595,256 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. S517S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00030 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00026 ( 1 hom. )

Consequence

CHRNA4
NM_000744.7 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.17

Publications

7 publications found
Variant links:
Genes affected
CHRNA4 (HGNC:1958): (cholinergic receptor nicotinic alpha 4 subunit) This gene encodes a nicotinic acetylcholine receptor, which belongs to a superfamily of ligand-gated ion channels that play a role in fast signal transmission at synapses. These pentameric receptors can bind acetylcholine, which causes an extensive change in conformation that leads to the opening of an ion-conducting channel across the plasma membrane. This protein is an integral membrane receptor subunit that can interact with either nAChR beta-2 or nAChR beta-4 to form a functional receptor. Mutations in this gene cause nocturnal frontal lobe epilepsy type 1. Polymorphisms in this gene that provide protection against nicotine addiction have been described. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
CHRNA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nocturnal frontal lobe epilepsy 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • familial sleep-related hypermotor epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nocturnal frontal lobe epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.007138163).
BP6
Variant 20-63349861-G-A is Benign according to our data. Variant chr20-63349861-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 205001.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 46 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000744.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
NM_000744.7
MANE Select
c.1550C>Tp.Ser517Leu
missense
Exon 5 of 6NP_000735.1P43681-1
CHRNA4
NM_001256573.2
c.1022C>Tp.Ser341Leu
missense
Exon 5 of 6NP_001243502.1Q4VAQ3
CHRNA4
NR_046317.2
n.1759C>T
non_coding_transcript_exon
Exon 5 of 6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA4
ENST00000370263.9
TSL:1 MANE Select
c.1550C>Tp.Ser517Leu
missense
Exon 5 of 6ENSP00000359285.4P43681-1
CHRNA4
ENST00000463705.5
TSL:1
n.2198C>T
non_coding_transcript_exon
Exon 4 of 5
CHRNA4
ENST00000467563.3
TSL:1
n.1620C>T
non_coding_transcript_exon
Exon 5 of 6

Frequencies

GnomAD3 genomes
AF:
0.000296
AC:
45
AN:
152212
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00559
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000521
AC:
121
AN:
232030
AF XY:
0.000452
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000607
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00478
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000270
Gnomad OTH exome
AF:
0.000532
GnomAD4 exome
AF:
0.000265
AC:
382
AN:
1442928
Hom.:
1
Cov.:
83
AF XY:
0.000246
AC XY:
176
AN XY:
715124
show subpopulations
African (AFR)
AF:
0.000151
AC:
5
AN:
33044
American (AMR)
AF:
0.0000922
AC:
4
AN:
43392
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25280
East Asian (EAS)
AF:
0.00211
AC:
83
AN:
39306
South Asian (SAS)
AF:
0.0000711
AC:
6
AN:
84364
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51450
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5644
European-Non Finnish (NFE)
AF:
0.000228
AC:
251
AN:
1101068
Other (OTH)
AF:
0.000556
AC:
33
AN:
59380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
25
50
75
100
125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000302
AC:
46
AN:
152328
Hom.:
0
Cov.:
33
AF XY:
0.000228
AC XY:
17
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41568
American (AMR)
AF:
0.0000653
AC:
1
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00579
AC:
30
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000181
Hom.:
0
Bravo
AF:
0.000272
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000481
AC:
58
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Autosomal dominant nocturnal frontal lobe epilepsy (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
16
DANN
Benign
0.85
DEOGEN2
Benign
0.22
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-0.88
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.70
T
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.0071
T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.27
N
PhyloP100
1.2
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.19
N
REVEL
Benign
0.19
Sift
Benign
0.41
T
Sift4G
Benign
0.36
T
Polyphen
0.0020
B
Vest4
0.11
MVP
0.71
MPC
0.52
ClinPred
0.0054
T
GERP RS
2.2
Varity_R
0.087
gMVP
0.18
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45622132; hg19: chr20-61981213; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.